WO2020003219A1 - Dérivés de pyrazole substitués à titre d'insecticides et de fongicides - Google Patents

Dérivés de pyrazole substitués à titre d'insecticides et de fongicides Download PDF

Info

Publication number
WO2020003219A1
WO2020003219A1 PCT/IB2019/055483 IB2019055483W WO2020003219A1 WO 2020003219 A1 WO2020003219 A1 WO 2020003219A1 IB 2019055483 W IB2019055483 W IB 2019055483W WO 2020003219 A1 WO2020003219 A1 WO 2020003219A1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
unsubstituted
alkyl
salt
pyrazole compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2019/055483
Other languages
English (en)
Inventor
Surendra Kumar KUMAWAT
Saurabh Arun KHOLE
Kiran Sadashiv BABAR
Manish Kumar YADAV
Ravi Kumar Sharma
Nand Kishor ARORA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OAT and IIL India Laboratories Pvt Ltd
Original Assignee
OAT and IIL India Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OAT and IIL India Laboratories Pvt Ltd filed Critical OAT and IIL India Laboratories Pvt Ltd
Publication of WO2020003219A1 publication Critical patent/WO2020003219A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Definitions

  • the present disclosure relates to novel pyrazole compounds and the process for preparing the said compounds. Furthermore, the disclosure provides an agriculture and horticulture insecticide and fungicide composition comprising the compounds of the present disclosure .
  • Patent Literature (PTL) 1 disclosed quinoline derivatives having fungicidal activity but there was no description for insecticidal activity.
  • WO 2006/013896 Patent Literature (PTL) 2
  • JP 2008-110953 Patent Literature (PTL) 3
  • JP 2633377 Patent Literature (PTL) 4
  • US 4168311 Patent Literature (PTL) 5
  • Patent Literature (PTL) 5 disclosed quinoline derivatives having an insecticidal activity.
  • PTL 1 and PTL 2 disclosed the compound represented by the following formula (A) :
  • Z represents an oxygen atom, a sulfur atom, SO, S0 2 , CO or Q, etc., where Q is a C1-4 alkylene group (the Ci- 4 alkylene group may be substituted with a halogen atom or a cyano group) ;
  • Ri, R 2 , and R 3 represent hydrogen, C 1-4 alkyl group, C 1-4 haloalkyl group, C 1-4 alkyloxy group, C 1-4 haloalkoxy group, alkyloxycarbonyl group, nitro group, cyano group, formyl group, acetyl group, acetylethoxy group, etc.;
  • R 2 and R 3 together represent one (CH 2 ) m , wherein m represents 3 or
  • Xi, X 2 , and X 3 each independently represent a hydrogen atom, a halogen atom, a Ci_ 4 alkyl group which may be substituted with a halogen atom or a Ci_ 4 alkyloxy group, a Ci_ 4 alkyloxycarbonyl group, a C 1-4 alkyloxy group which may be substituted with a halogen atom, or a C 1-4 alkyloxycarbonyl group which may be substituted by a halogen atom, with the proviso that X 2 , X 2 , and X 3 do not simultaneously represent hydrogen atoms;
  • Wi represents a nitrogen atom or CY 2 ,
  • W 2 represents a nitrogen atom or CY 2 .
  • W 3 represents a nitrogen atom or CY 3 ,
  • W 2 and W 3 represent CY 2 and CY 3 , respectively, when W 2 represents a nitrogen atom, Wi and W 3 represent CY 2 and CY 3 , respectively, and when W 3 represents a nitrogen atom, W 2 and W 2 represent CY 2 and CY 2 , respectively;
  • Yi, Y 2 and Y 3 each independently represent a hydrogen atom, A, or
  • A represents a Ci-s alkyl group, Ci-s alkyloxy group, C 2- s alkenyl group, C 2-8 alkenyloxy group, Ci-s alkyloxycarbonyl group, C 2-8 alkenylthio group, C 1-8 alkylsulfinyl group, C 2- s alkenylsulfinyl group, C 1-8 alkylsulfonyl group, C 2-8 alkenylsulfonyl group, phenyl group, or phenoxy group, wherein all these substituents may further be substituted with various groups, such as halogen, C 1-4 alkyl group, etc., and
  • B represents a halogen atom, or a C 1-4 alkyl group.
  • the present disclosure provides novel substituted pyrazole compounds or salts thereof which exhibit high insecticidal and fungicidal activity against drug resistant insects and fungi as well as drug sensitive insects and fungi.
  • the present disclosure also provides a process for preparing the said novel substituted pyrazole compounds or salts thereof.
  • the present disclosure further provides a new type of agriculture and horticulture composition
  • a substituted pyrazole compound or a salt thereof as an active ingredient, which exhibits a remarkable insecticidal and fungicidal effect against chemical-resistant as well as chemical-sensitive insects and fungi.
  • the present inventors conducted extensive research, and succeeded in synthesizing a compound represented by the following formula (1) or a salt thereof that has shown excellent insecticidal and fungicidal activities.
  • the present inventors have conducted further research based on the above findings.
  • the present disclosure relates to novel substituted pyrazole compounds or salts thereof represented by the following general formula (1) .
  • the present disclosure includes the following embodiments:
  • Embodiment A1 is a diagrammatic representation of Embodiment A1 :
  • a substituted pyrazole compound represented by formula (1) A substituted pyrazole compound represented by formula (1) :
  • Q represents an oxygen atom, a sulfur atom, CR. 6 R 7 or direct bond.
  • R 6 and R 7 each independently represent hydrogen, halogen, cyano, C 1 -C 12 alkyl, C 1 -C 12 haloalkyl, C 1 -C 12 alkoxy, C 1 -C 12 haloalkoxy, C 1 -C 12 cyanoalkoxy, C 1 -C 12 alkylthio, C 1 -C 12 haloalkylthio, C 1 -C 12 alkoxy, C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy, C 2 -Ci 2 alkenyl, C 2 -Ci 2 haloalkenyl, C 2 -Ci 2 alkenyloxy, C 2 -Ci 2 haloalkenyloxy, C 2 -Ci 2 alkynyl, C 2 -Ci 2 haloalkynyl, C 2 -Ci 2
  • R represents substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aryl Ci-Ci 2 alkyl, substituted or unsubstituted heteroaryl Ci-Ci 2 alkyl, Ci-Ci 2 alkyl, Ci-Ci 2 haloalkyl, Ci-Ci 2 cyanoalkyl, Ci-Ci 2 alkoxy Ci-Ci 2 alkyl, Ci-Ci 2 alkylthio Ci-Ci 2 alkyl, Ci-Ci 2 haloalkoxy Ci-Ci 2 alkyl, C 2 -Ci 2 alkenyl, C 2 -Ci 2 alkynyl, C 2 -Ci 2 haloalkenyl, C 2 -Ci 2 haloalkynyl, Ci-Ci 2 alkylsulfinyl, Ci-Ci 2 alkylsulfonyl, Ci-Ci 2 haloal
  • Ri represents hydrogen, substituted or unsubstituted Ci-Ci 2 alkyl, substituted or unsubstituted C 2 -Ci 2 alkenyl, substituted or unsubstituted C 2 -Ci 2 alkynyl, substituted or unsubstituted C 3 -Ci 2 cycloalkyl, substituted or unsubstituted aryl Ci-Ci 2 alkyl, substituted or unsubstituted Ci-Ci 2 alkylcarbonyl, substituted or unsubstituted Ci-Ci 2 haloalkylcarbonyl, substituted or unsubstituted Ci-Ci 2 haloalkoxycarbonyl, substituted or unsubstituted C 2 -C 12 alkenylcarbonyl , substituted or unsubstituted C 2 - C 12 alkynylcarbonyl , substituted or unsubstituted C 3 - C 12 cycloalkylcarbonyl , substitute
  • R 2 represents hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, or substituted or unsubstituted C 1 -C 12 haloalkoxy;
  • R 3 represents hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 haloalkoxy, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 - C 12 cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic;
  • R 4 and R 5 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, or substituted or unsubstituted aryl;
  • Xi represents C-Rs or N
  • X 2 represents C-R 9 or N
  • X 3 represents C-R 10 or N
  • Re , R 9 and Rio each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 haloalkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, substituted or unsubstituted C 1 -C 12 haloalkylthio, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted C 1 -C 12 haloalkoxycarbonyl , cyano, nitro or substituted or unsubstituted amino .
  • Embodiment A2 is a diagrammatic representation of Embodiment A2 :
  • Embodiment A3 is a diagrammatic representation of Embodiment A3 :
  • substituted pyrazole compound or a salt thereof according to any one of embodiments A1 or A2, wherein R represents substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or C 1 -C 12 alkyl.
  • Embodiment A4 is a diagrammatic representation of Embodiment A4 :
  • substituted pyrazole compound or a salt thereof according to any one of embodiments A1 to A3, wherein Ri represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl , substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl , substituted or unsubstituted C 1 -C 12 alkoxycarbonyl , substituted or unsubstituted arylcarbonyl , substituted or unsubstituted aryloxycarbonyl , substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted arylsulfinyl, or substituted or unsubsti
  • R 2 represents hydrogen, halogen, substituted or unsubstituted C1-C12 alkyl, or substituted or unsubstituted Ci-Ci 2 haloalkyl.
  • Embodiment A6 is a diagrammatic representation of Embodiment A6 :
  • R 3 represents substituted or unsubstituted Ci-Ci 2 alkyl, or substituted or unsubstituted Ci-Ci 2 haloalkyl .
  • Embodiment A7
  • R 4 and R5 each independently represent hydrogen, halogen, substituted or unsubstituted Ci-Ci 2 alkyl, or substituted or unsubstituted Ci-Ci 2 haloalkyl .
  • Embodiment A8 is a diagrammatic representation of Embodiment A8 :
  • substituted pyrazole compound or a salt thereof according to any one of embodiments A1 to A7, wherein X 2 represents C-Rs, X 2 represents C-Rg, and X3 represents C-R10, wherein Rg, R9 and Rio are independently of each other hydrogen, halogen, substituted or unsubstituted Ci-Ci 2 alkyl, substituted or unsubstituted Ci-Ci 2 haloalkyl, or substituted or unsubstituted Ci-Ci 2 alkoxy.
  • Embodiment A9
  • a pest controlling agent comprising the substituted pyrazole compound or a salt thereof according to any one of embodiments A1 to A8 as an active ingredient.
  • Embodiment A10
  • Embodiment All A method for controlling pests, which comprises applying the substituted pyrazole compound or a salt thereof according to any one of embodiments A1 to A8 to a plant or its vicinity, or soil where a plant is cultivated.
  • Embodiment A12 is a diagrammatic representation of Embodiment A12
  • a method for controlling pests which comprises applying an effective amount of the substituted pyrazole compound or a salt thereof according to any one of embodiments A1 to A8 to pests, a habitat of a pests, or a place where inhabitation is predicted.
  • the present disclosure includes the following embodiments:
  • Embodiment 1 is a diagrammatic representation of Embodiment 1 :
  • a substituted pyrazole compound represented by formula (1) A substituted pyrazole compound represented by formula (1) :
  • Q represents an oxygen atom, a sulfur atom, CR. 6 R 7 or direct bond;
  • R 3 ⁇ 4 and R 7 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, substituted or unsubstituted C 2 -Ci 2 alkenyl, substituted or unsubstituted C 2 -Ci 2 alkenyloxy, substituted or unsubstituted C 2 -Ci 2 alkynyl, substituted or unsubstituted C 2 -Ci 2 alkynyloxy, substituted or unsubstituted Ci-Ci 2 alkylsulfinyl, substituted or unsubstituted Ci-Ci 2 alkylsulfonyl, substituted or unsubstituted C 3 -C
  • R represents hydrogen, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -Ci 2 alkynyl, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl , substituted or unsubstituted C 1 -C 12 alkoxycarbonyl , substituted or unsubstituted C 3 -C 12 cycloalkyl, or substituted or unsubstituted saturated heterocyclic;
  • Ri represents hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -Ci 2 alkenyl, substituted or unsubstituted C 2 -Ci 2 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 2 -Ci 2 alkenylcarbonyl , substituted or unsubstituted C 2 -Ci 2 alkynylcarbonyl , substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl , substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted aryloxycarbonyl , substituted or unsubstituted heteroaryloxycarbonyl , substituted or unsubstituted
  • R 2 and R 3 each independently represents hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocyclic;
  • R 4 and R 5 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio or substituted or unsubstituted aryl;
  • Xi represents C-Rs or N
  • X 2 represents C-R 9 or N
  • X 3 represents C-Rio or N
  • R 9 and Rio each independently represent hydrogen, halogen, substituted or unsubstituted Ci-Ci 2 alkyl, substituted or unsubstituted Ci-Ci 2 alkoxy, substituted or unsubstituted Ci-Ci 2 alkylthio, substituted or unsubstituted Ci-Ci 2 alkoxycarbonyl , cyano, nitro, or substituted or unsubstituted amino.
  • Ci-Ci 2 alkyl is selected from the group consisting of Ci-Ci 2 alkyl, Ci-Ci 2 haloalkyl, Ci-Ci 2 alkoxy Ci-Ci 2 alkyl, and Ci-Ci 2 haloalkoxy Ci-Ci 2 alkyl;
  • Ci-Ci 2 alkoxy is selected from the group consisting of Ci-Ci 2 alkoxy, Ci-Ci 2 haloalkoxy, and Ci-Ci 2 cyanoalkoxy;
  • said substituted or unsubstituted Ci-Ci 2 alkylthio is selected from the group consisting of Ci-Ci 2 alkylthio and Ci-Ci 2 haloalkylthio ; said substituted or unsubstituted C 2 -Ci 2 alkenyl is selected from the group consisting of C 2 -Ci 2 alkenyl and C 2 -Ci 2 haloalkenyl; said substituted or unsubstituted C 2 -Ci 2 alkenyloxy is selected from the group consisting of C 2 -Ci 2 alkenyloxy and C 2 -Ci 2 haloalkenyloxy; said substituted or unsubstituted C 2 -Ci 2 alkynyl is selected from the group consisting of C 2 -Ci 2 alkynyl and C 2 -Ci 2 haloalkynyl; said substituted or unsubstituted C 2 -Ci 2 alkynyloxy is selected from
  • Ci-Ci 2 alkylsulfonyl is selected from the group consisting of Ci-Ci 2 alkylsulfonyl and Ci-Ci 2 haloalkyl sulfonyl ;
  • said substituted or unsubstituted C 3 -Ci 2 cycloalkyl is C 3 -Ci 2 cycloalkyl ;
  • said substituted or unsubstituted C 1 -C 12 alkylcarbonyl is selected from the group consisting of C 1 -C 12 alkylcarbonyl and C 1 -C 12 haloalkylcarbonyl ;
  • said substituted or unsubstituted C 1 -C 12 alkoxycarbonyl is selected from the group consisting of C 1 -C 12 alkoxycarbonyl and C 1 -C 12 haloalkoxycarbonyl ;
  • said substituted or unsubstituted C 1 -C 12 alkylcarbonylamino is C 1 -C 12 alkylcarbonylamino
  • said substituted or unsubstituted C 1 -C 12 alkylsulfonyloxy is C 1 -C 12 alkylsulfonyloxy;
  • said substituted or unsubstituted C 1 -C 12 alkylsulfinyloxy is C 1 -C 12 alkylsulfinyloxy .
  • said substituted or unsubstituted C 1 -C 12 alkyl is selected from the group consisting of C 1 -C 12 alkyl, C 1 -C 12 haloalkyl, C 1 -C 12 cyanoalkyl, C 1 -C 12 alkoxy C 1 -C 12 alkyl, C 1 -C 12 alkylthio C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy C 1 -C 12 alkyl, substituted or unsubstituted aryl C 1 -C 12 alkyl, and substituted or unsubstituted hetroaryl aryl C 1 -C 12 alkyl; said substituted or unsubstituted C 2 -Ci 2 alkenyl is selected from the group consisting of C 2 -Ci 2 alkenyl and C 2 -Ci 2 haloalkenyl; said substituted or unsubstituted C 2 -Ci 2 alkynyl is
  • Ci-Ci 2 alkylsulfonyl is selected from the group consisting of Ci-Ci 2 alkylsulfonyl and Ci-Ci 2 haloalkyl sulfonyl ;
  • Ci-Ci 2 alkylcarbonyl is selected from the group consisting of Ci-Ci 2 alkylcarbonyl Ci-Ci 2 haloalkylcarbonyl ;
  • Ci-Ci 2 alkoxycarbonyl is selected from the group consisting of Ci-Ci 2 alkoxycarbonyl and Ci-Ci 2 haloalkoxycarbonyl; and/or
  • substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments, wherein, in Ri, said substituted or unsubstituted C 1 -C 12 alkyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkyl and substituted or unsubstituted aryl C 1 -C 12 alkyl;
  • said substituted or unsubstituted C 1 -C 12 alkylcarbonyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 haloalkylcarbonyl , substituted or unsubstituted aryl C 1 -C 12 alkylcarbonyl, substituted or unsubstituted heteroaryl C 1 -C 12 alkylcarbonyl, substituted or unsubstituted heterocycle C 1 -C 12 alkylcarbonyl, and substituted or unsubstituted C 3- Ci 2 cycloalkyl C 1 -C 12 alkylcarbonyl;
  • said substituted or unsubstituted C 1 -C 12 alkoxycarbonyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted aryl C 1 -C 12 alkoxycarbonyl, and substituted or unsubstituted heteroaryl C 1 -C 12 alkoxycarbonyl ;
  • substituted or unsubstituted C 1 -C 12 alkylsulfinyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkylsulfinyl, and substituted or unsubstituted C 1 -C 12 haloalkylsulfinyl ; and/or
  • said substituted or unsubstituted C 1 -C 12 alkylsulfonyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkylsulfonyl, and C 1 -C 12 haloalkylsulfonyl ;
  • Ri can also be further substituted by various substituents groups, such as F, Cl, Br, I, CN, N0 2 , CH 3 , C(CH 3 ) 3 , OCH 3 , C0 2 CH 3 , C0 2 CH 2 CH 3 , S0 2 CH 3 , OCH 2 CF 3 , CF 3 , or OCF 3 .
  • substituents groups such as F, Cl, Br, I, CN, N0 2 , CH 3 , C(CH 3 ) 3 , OCH 3 , C0 2 CH 3 , C0 2 CH 2 CH 3 , S0 2 CH 3 , OCH 2 CF 3 , CF 3 , or OCF 3 .
  • substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments, wherein, in R 2 , said substituted or unsubstituted C 1 -C 12 alkyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl; and/or
  • said substituted or unsubstituted C 1 -C 12 alkoxy is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxy, and substituted or unsubstituted C 1 -C 12 haloalkoxy.
  • said substituted or unsubstituted C 1 -C 12 alkyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl; and/or
  • said substituted or unsubstituted C 1 -C 12 alkoxy is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxy, and substituted or unsubstituted C 1 -C 12 haloalkoxy.
  • substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments, wherein, in R 4 and R 5 , said substituted or unsubstituted C 1 -C 12 alkyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl.
  • substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments, wherein, in R 8 , R 9 and Rio, said substituted or unsubstituted C 1 -C 12 alkyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl;
  • said substituted or unsubstituted C 1 -C 12 alkoxy is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxy, and substituted or unsubstituted C 1 -C 12 haloalkoxy;
  • substituted or unsubstituted C 1 -C 12 alkylthio is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkylthio, and substituted or unsubstituted C 1 -C 12 haloalkylthio ; and/or
  • said substituted or unsubstituted C 1 -C 12 alkoxycarbonyl is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, and substituted or unsubstituted C 1 -C 12 haloalkoxycarbonyl .
  • Q represents an oxygen atom or a sulfur atom
  • R represents substituted or unsubstituted aryl, substituted or unsubstituted C 1 -C 12 alkyl,
  • Ri represents hydrogen, substituted or unsubstituted C 2 -Ci 2 alkenyl, substituted or unsubstituted C 2 -Ci 2 alkynyl, substituted or unsubstituted Ci-Ci 2 alkylcarbonyl , substituted or unsubstituted C 3 -Ci 2 cycloalkylcarbonyl , substituted or unsubstituted Ci-Ci 2 alkoxycarbonyl , substituted or unsubstituted aryloxycarbonyl , substituted or unsubstituted arylcarbonyl , or substituted or unsubstituted Ci-Ci 2 alkylsulfonyl ;
  • R 2 represents hydrogen, or substituted or unsubstituted Ci-Ci 2 alkyl
  • R 3 represents substituted or unsubstituted Ci-Ci 2 alkyl
  • R 4 and R 5 each independently represent hydrogen, substituted or unsubstituted Ci-Ci 2 alkyl
  • Xi represents C-R 3 or N
  • X 2 represents C-Rg
  • X 3 represents C-R 10 .
  • R 8 , Rg and Rio each independently represent hydrogen, halogen, substituted or unsubstituted Ci-Ci 2 alkyl, or substituted or unsubstituted Ci-Ci 2 alkoxy.
  • Embodiment 2 is a diagrammatic representation of Embodiment 1 :
  • Embodiment 3 is a diagrammatic representation of Embodiment 3 :
  • R represents substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted Ci-Ci 2 alkyl.
  • Embodiment 4 The substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments, wherein R represents substituted or unsubstituted C 6 -C 10 aryl, or unsubstituted C 1 -C 12 alkyl .
  • Embodiment 5
  • Embodiment 6 is a diagrammatic representation of Embodiment 6 :
  • R 2 represents hydrogen, substituted or unsubstituted C 2 -C 22 alkenyl, unsubstituted C 2 -Ci 2 alkynyl, unsubstituted Ci-Ci 2 alkylcarbonyl, unsubstituted C 3 -Ci 2 cycloalkylcarbonyl, unsubstituted Ci-Ci 2 alkoxycarbonyl, substituted or unsubstituted C 6 -C 10 arylcarbonyl, unsubstituted C 6 -C 10 aryloxycarbonyl, or unsubstituted C 6 -C 10 arylsulfonyl .
  • Embodiment 7
  • R 2 represents hydrogen, halogen, or substituted or unsubstituted Ci-Ci 2 alkyl.
  • Embodiment 8
  • R 2 represents hydrogen, or unsubstituted Ci-Ci 2 alkyl.
  • Embodiment 9 The substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments, wherein R 3 represents substituted or unsubstituted C 1 -C 12 alkyl.
  • Embodiment 10 is a diagrammatic representation of Embodiment 10:
  • R 4 and R 5 each independently represent hydrogen, halogen, or substituted or unsubstituted C 1 -C 12 alkyl.
  • Embodiment 11 is a diagrammatic representation of Embodiment 11:
  • R 4 and R 5 each independently represent hydrogen, or unsubstituted C 1 -C 12 alkyl.
  • Embodiment 12 is a diagrammatic representation of Embodiment 12
  • X 4 represents C-R 8
  • X 2 represents C-R 9
  • X 3 represents C-R 10
  • R 8 , R 9 and Ri 0 are independently of each other hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or unsubstituted C 1 -C 12 alkoxy .
  • Embodiment 13 is a diagrammatic representation of Embodiment 13:
  • X 4 represents C-R 8
  • X 2 represents C-Rg
  • X 3 represents C-R 10
  • R 8 , Rg and Rio are independently of each other hydrogen, halogen, substituted or unsubstituted Ci-Ci 2 alkyl, or unsubstituted Ci-Ci 2 alkoxy.
  • Embodiment 14 is a diagrammatic representation of Embodiment 14:
  • Embodiment 15 is a diagrammatic representation of Embodiment 15:
  • Embodiment 17 is a diagrammatic representation of Embodiment 17:
  • Embodiment 18 is a diagrammatic representation of Embodiment 18:
  • Embodiment 19 is a diagrammatic representation of Embodiment 19:
  • R 4 and R5 each independently represent hydrogen, or unsubstituted C1-C6 alkyl.
  • Embodiment 20 is a diagrammatic representation of Embodiment 20.
  • Xi represents C-Rs
  • X 2 represents C-Rg
  • X 3 represents C-R10
  • Rs, R 9 and Rio are, independently of each other, hydrogen, halogen, unsubstituted C1-C6 alkyl, or unsubstituted C1-C6 alkoxy.
  • Embodiment 21 is a diagrammatic representation of Embodiment 21.
  • a pest controlling agent comprising the substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments as an active ingredient.
  • Embodiment 22 is a diagrammatic representation of Embodiment 22.
  • Embodiment 23 A method for using the substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments for controlling pests.
  • a method for controlling pests which comprises applying the substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments to a plant or its vicinity, or soil where a plant is cultivated.
  • Embodiment 24 is a diagrammatic representation of Embodiment 24.
  • a method for controlling pests which comprises applying an effective amount of substituted pyrazole compound or a salt thereof according to any one of the preceding embodiments to pests, a habitat of a pests, or a place where inhabitation is predicted.
  • a novel substituted pyrazole compound or a salt thereof according to the present disclosure achieves an excellent insecticidal and fungicidal effect. Additionally, the pyrazole compound or a salt thereof according to the present disclosure is useful as a new type of insecticide and fungicide that exhibit excellent insecticidal and fungicidal effect not only against chemical-sensitive fungi, but also against chemical-resistant fungi .
  • the present disclosure is directed to a compound represented by Formula ( 1 ) :
  • R, Ri, R 2 , R 3 , R 4 , R 5 , Xi, X 2 , X 3 , and Q are as defined above.
  • the number of substituents of a group defined by "substituted” is not particularly limited if it is substitutable, and is one or plural .
  • the description for each group is also applied when the group is one part of or a substituent on other groups.
  • Ci-Ci 2 alkyl means a linear or branched, saturated hydrocarbon group having one to twelve carbon atoms.
  • C 1 -C 6 alkyl or “C 1 -C 3 alkyl” means a linear or branched, saturated hydrocarbon group having one to six or one to three carbon atoms, respectively.
  • C 2 -Ci 2 alkenyl means a linear or branched, unsaturated hydrocarbon group having two to twelve carbon atoms and containing one to three double bonds.
  • C 2 -Ci 2 alkynyl means a linear or branched, unsaturated hydrocarbon group having two to twelve carbon atoms and containing one triple bond.
  • C 3 -Ci 2 cycloalkyl means a cyclic alkyl having three to twelve carbon atoms, and includes those cyclic alkyl having a partially bridged structure.
  • C 3 -C 6 cycloalkyl means a cyclic alkyl having three to six carbon atoms.
  • C 1 -C 12 alkoxy refers to a "C 1 -C 12 alkyloxy group", wherein the "C 1 -C 12 alkyl” moiety is defined the same as the above-described "C 1 -C 12 alkyl”.
  • Aryl means a monocyclic or polycyclic aromatic hydrocarbon.
  • C 6 -C 10 aryl means an aryl group, as defined herein, having six to ten carbon atoms.
  • C 6 aryl means an aryl group, as defined herein, having six carbon atoms.
  • Heterocyclic means a saturated, unsaturated, or aromatic heterocyclic group which has at least one of nitrogen, oxygen, phosphorus and/or sulfur atoms in the ring and may be bonded at any substitutable position.
  • Heterocyclic may be referred to as “heterocycle” or “heterocyclyl " .
  • Heteroaryl means an aromatic heterocyclic group which has at least one of nitrogen, oxygen, and/or sulfur atoms in the ring and may be bonded at any substitutable position, wherein the ring member atoms of the heteroaryl besides carbon atoms include 1, 2, 3 or 4 heteroatoms selected from N, 0 and S .
  • halogen examples include, but are not particularly limited to, fluorine, chlorine, bromine, iodine, and the like.
  • C 1 -C 12 alkyl examples include, but are not particularly limited to, C 1 -C 12 straight-chain or branched-chain alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, 1, 1-dimethylpropan-l-yl, n-hexyl, 1-ethylpentyl, 2-ethylhexyl , and the like.
  • C 1 -C 12 straight-chain or branched-chain alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, 1, 1-di
  • C 1 -C 12 haloalkyl examples include, but are not particularly limited to, C 1 -C 12 straight-chain or branched-chain alkyl substituted with 1 to 9, preferably 1 to 8, halogen atoms, such as fluoromethyl , chloromethyl , bromomethyl, iodomethyl, difluoromethyl, 2, 2-difluoroethyl, trifluoromethyl,
  • C1-C12 alkoxy examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkoxy, such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentyloxy, isopentyloxy, neopentyloxy,
  • C1-C12 haloalkoxy examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkoxy substituted with 1 to 9, preferably 1 to 8, halogen atoms, such as fluoromethoxy, chloromethoxy, bromomethoxy, iodomethoxy, difluoromethoxy, 2 , 2-difluoroethoxy, trifluoromethoxy,
  • C1-C12 alkoxy C1-C12 alkyl examples include, but are not particularly limited to, alkoxyalkyl in which the C1-C12 straight-chain or branched-chain alkyl is substituted with a C1-C12 straight-chain or branched-chain alkoxy, such as methoxymethyl , ethoxymethyl , n-propoxymethyl , isopropoxymethyl , n-butoxymethyl , isobutoxymethyl , sec-butoxymethyl , tert-butoxymethyl , methoxyethyl , ethoxyethyl, methoxy-n-propyl , methoxy-n-butyl , and the like.
  • C1-C12 haloalkoxy C1-C12 alkyl examples include, but are not particularly limited to, straight-chain or branched-chain alkoxyalkyl substituted with 1 to 9, preferably 1 to 8, halogen atoms, such as fluoromethoxymethyl , chloromethoxymethyl , bromomethoxymethyl , iodomethoxymethyl , difluoromethoxymethyl, trifluoromethoxymethyl, 2, 2, 2-trifluoroethoxymethyl, and the like .
  • C3-C12 cycloalkyl examples include, but are not particularly limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and the like.
  • C3-C12 cycloalkylcarbonyl examples include, but are not particularly limited to, cyclopropylcarbonyl , cyclobutylcarbonyl , cyclopentylcarbonyl , cyclohexylcarbonyl and the like.
  • C1-C12 alkylcarbonyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylcarbonyl groups, such as methylcarbonyl (acetyl), ethylcarbonyl (propionyl), n-propylcarbonyl (butyryl), isopropylcarbonyl ( isobutyryl ) , n-butylcarbonyl (valeryl), isobutylcarbonyl ( isovaleryl ) , sec-butylcarbonyl , tert-butylcarbonyl , n-pentylcarbonyl , isopentylcarbonyl , neopentylcarbonyl , (1, 1-dimethylpropan-l-yl ) carbonyl,
  • C1-C12 haloalkylcarbonyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylcarbonyl substituted with 1 to 9, preferably 1 to 5, halogen atoms, such as fluoromethylcarbonyl , chloromethylcarbonyl , bromomethylcarbonyl , iodomethylcarbonyl , dichloromethylcarbonyl , trichloromethylcarbonyl, difluoromethylcarbonyl , trifluoromethylcarbonyl, chiorodifluoromethylcarbonyl , bromodifluoromethylcarbonyl , dichlorofluoromethylcarbonyl , 2,2, 2-trichloroethylcarbonyl , 2,2, 2-trifluoroethylcarbonyl , pentafluoroethylcarbonyl , and the like.
  • halogen atoms such as fluoromethylcarbonyl , chloromethylcarbonyl
  • C1-C12 alkoxycarbonyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkoxycarbonyl, such as methoxycarbonyl , ethoxycarbonyl , n-propoxycarbonyl , isopropoxycarbonyl , n-butoxycarbonyl , isobutoxycarbonyl , sec-butoxycarbonyl , tert-butoxycarbonyl , n-pentyloxycarbonyl , isopentyloxycarbonyl , neopentyloxycarbonyl , (1, 1-dimethylpropan-l-yloxy) carbonyl, n-hexyloxycarbonyl ,
  • Ci-Ci 2 haloalkoxycarbonyl examples include, but are not particularly limited to, Ci-Ci 2 straight-chain or branched-chain alkoxycarbonyl substituted with 1 to 9, preferably 1 to 5, halogen atoms, such as fluoromethoxycarbonyl , chloromethoxycarbonyl , bromomethoxycarbonyl , iodomethoxycarbonyl , dichioromethoxycarbonyl, trichloromethoxycarbonyl , difluoromethoxycarbonyl , trifluoromethoxycarbonyl ,
  • C1-C12 cyanoalkyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkyl substituted with a cyano group, such as cyanomethyl, cyanoethyl, cyano-n-propyl , cyano-isopropyl , cyano-n-butyl , cyano-isobutyl , cyano-sec-butyl , cyano-tert-butyl , cyano-n-hexyl , and the like.
  • a cyano group such as cyanomethyl, cyanoethyl, cyano-n-propyl , cyano-isopropyl , cyano-n-butyl , cyano-isobutyl , cyano-sec-butyl , cyano-tert-butyl , cyano-n-hexyl , and the like.
  • C1-C12 cyanoalkoxy examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkoxy substituted with a cyano group, such as cyanomethoxy, cyanoethoxy, cyano-n-propoxy, cyano-isopropoxy, cyano-n-butoxy, cyano-iso-butoxy, cyano-sec-butoxy, cyano-tert-butoxy, cyano-hexyloxy, and the like.
  • a cyano group such as cyanomethoxy, cyanoethoxy, cyano-n-propoxy, cyano-isopropoxy, cyano-n-butoxy, cyano-iso-butoxy, cyano-sec-butoxy, cyano-tert-butoxy, cyano-hexyloxy, and the like.
  • C 2 -Ci 2 alkenyl examples include, but are not particularly limited to, vinyl, allyl, 2-butenyl, 3-butenyl, 1-methylallyl, and the like.
  • C 2 -Ci 2 haloalkenyl examples include, but are not particularly limited to, 2 , 2-dichlorovinyl , 2 , 2-dibromovinyl , 2, 2-difluorovinyl, 3, 3-difluoro-2-allyl, 4, 4-difluoro-3-butenyl ,
  • C 2 -Ci 2 alkynyl examples include, but are not particularly limited to, ethynyl, 2-propynyl (propargyl), l-methyl-2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, and the like.
  • C 2 -Ci 2 haloalkynyl examples include, but are not particularly limited to, fluoroethynyl , bromoethynyl , chloroethynyl , iodoethynyl, 3, 3, 3-trifluoro-l-propynyl, and the like .
  • C1-C12 alkylsulfinyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylsulfinyl, such as methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl, tert-butylsulfinyl, and the like .
  • C1-C12 alkylsulfinyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylsulfinyl, such as methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-but
  • C1-C12 haloalkylsulfinyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylsulfinyl substituted with 1 to 9, preferably 1 to 5, halogen atoms, such as fluoromethylsulfinyl, chloromethylsulfinyl, bromomethylsulfinyl , iodomethylsulfinyl , dichloromethylsulfinyl , trichloromethylsulfinyl, difluoromethylsulfinyl , trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfinyl , dichlorofluoromethylsulfinyl , 2,2, 2-trichloroethylsulfinyl , 2,2, 2-trifluoroethylsulfinyl, pentafluor
  • C1-C12 alkylsulfonyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylsulfonyl groups, such as methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl, tert-butylsulfonyl, and the like .
  • C1-C12 haloalkylsulfonyl examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylsulfonyl substituted with 1 to 9, preferably 1 to 5, halogen atoms, such as fluoromethylsulfonyl, chloromethylsulfonyl, bromomethylsulfonyl , iodomethylsulfonyl , dichloromethylsulfonyl , trichloromethylsulfonyl, difluoromethylsulfonyl , trifluoromethylsulfonyl, chlorodifluoromethylsulfonyl, bromodifluoromethylsulfonyl , dichlorofluoromethylsulfonyl , 2,2, 2-trichloroethylsulfonyl , 2,2, 2-trifluoroethylsulfonyl, pentafluor
  • C1-C12 alkylthio examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylthio, such as methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio, tert-butylthio, and the like.
  • C1-C12 haloalkylthio examples include, but are not particularly limited to, C1-C12 straight-chain or branched-chain alkylthio substituted with 1 to 9, preferably 1 to 5, halogen atoms, such as fluoromethylthio, chloromethylthio, bromomethylthio, iodomethylthio, dichloromethylthio, trichloromethylthio, difluoromethylthio, trifluoromethylthio, chiorodifluoromethylthio, bromodifluoromethylthio, dichlorofluoromethylthio, 2,2, 2-trichloroethylthio,
  • C 2 -Ci 2 alkenyloxy examples include, but are not particularly limited to, vinyloxy, 1-propenyloxy, isopropenyloxy, allyloxy,
  • C 2 -Ci 2 haloalkenyloxy examples include, but are not particularly limited to, 2 , 2-dichlorovinyloxy,
  • C 2 -Ci 2 alkynyloxy examples include, but are not particularly limited to, ethynyloxy, 2-propynyloxy, l-methyl-2-propynyloxy,
  • C 2 -Ci 2 haloalkynyloxy examples include, but are not particularly limited to, fluoroethynyloxy, bromoethynyloxy, chloroethynyloxy, iodoethynyloxy, 3, 3, 3-trifluoro-l-propynyloxy, and the like.
  • Ci-Ci 2 alkylsulfonyloxy examples include, but are not particularly limited to, Ci-Ci 2 straight-chain or branched-chain alkylsulfonyl groups, such as methylsulfonyloxy, ethylsulfonyloxy, n-propylsulfonyloxy, isopropylsulfonyloxy, n-butylsulfonyloxy, isobutylsulfonyloxy, sec-butylsulfonyloxy, tert-butylsulfonyloxy, and the like.
  • C 1 -C 12 alkylsulfinyloxy examples include, but are not particularly limited to, C 1 -C 12 straight-chain or branched-chain alkylsulfinyloxy groups, such as methylsulfinyloxy, ethylsulfinyloxy, n-propylsulfinyloxy, isopropylsulfinyloxy, n-butylsulfinyloxy, isobutylsulfinyloxy, sec-butylsulfinyloxy, tert-butylsulfinyloxy, and the like.
  • C 1 -C 12 alkylsulfinyloxy examples include, but are not particularly limited to, C 1 -C 12 straight-chain or branched-chain alkylsulfinyloxy groups, such as methylsulfinyloxy, ethylsulfinyloxy, n-propylsulfin
  • substituted or unsubstituted amino include, but are not particularly limited to, amino, monoalkylamino, dialkylamino, monoacylamino, and the like.
  • alkyl include C 1 -C 12 alkyl mentioned above, and the like.
  • acyl include C 1 -C 12 alkoxycarbonyl , haloalkoxycarbonyl , arylcarbonyl mentioned above, and the like.
  • aryl examples include, but are not particularly limited to, phenyl, 1-naphthyl, 2-naphthyl, and the like.
  • aryl C 1 -C 12 alkyl examples include, but are not particularly limited to, benzyl, phenylethyl, phenyl-n-propyl and the like. These aryl C 1 -C 12 alkyl can be further substituted at the alkyl part or the aryl part, or both.
  • aryloxy examples include, but are not particularly limited to, phenoxy, 1-naphthyloxy, 2-naphthyloxy, and the like.
  • aryl C 1 -C 12 alkoxy examples include, but are not particularly limited to, benzyloxy, phenylethoxy, phenyl-n-propoxy, phenyl-n-butoxy, 1-naphthylmethoxy, 2-naphthylmethoxy, and the like .
  • heteroaryloxy examples include, but are not particularly limited to, pyridinyloxy, pyrimidinyloxy, pyrazolyloxy, and the like .
  • heteroaryl C 1 -C 12 alkoxy examples include, but are not particularly limited to, pyridinylmethoxy, pyridinylethoxy, pyrimidinylethoxy, pyrazolylmethoxy, and the like.
  • arylsulfonyl examples include, but are not particularly limited to, phenylsulfonyl, 1 -naphthylsulfonyl, 2-naphthylsulfonyl, and the like.
  • arylsulfinyl examples include, but are not particularly limited to, phenylsulfinyl, 1 -naphthylsulfinyl, 2-naphthylsulfinyl, and the like.
  • heteroaryl examples include, but are not particularly limited to, thienyl, furyl, pyrrolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl , pyrazolyl, imidazolyl, oxadiazolyl, thiadiazolyl , triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, isoindolyl, indazolyl, quinazolinyl , carbazolyl, benzoxazolyl , benzisoxazolyl , benzothiazolyl , benzisothiazolyl , benzimidazolyl , quinolinyl, isoquinolinyl , pyridoindolyl , cinnolinyl,
  • All the Aryls and Heteroaryls mentioned above may optionally be further substituted.
  • Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5) .
  • heterocyclic group examples include, but are not particularly limited to, thienyl, furyl, tetrahydrofuryl, dioxolanyl, dioxanyl, pyrrolyl, pyrrolinyl, pyrrolidinyl , oxazolyl, isoxazolyl, oxazolinyl, oxazolidinyl , isoxazolinyl , thiazolyl, isothiazolyl, thiazolinyl, thiazolidinyl , isothiazolinyl , pyrazolyl, pyrazolidinyl , imidazolyl, imidazolinyl , imidazolidinyl , oxadiazolyl, oxadiazolinyl , thiadiazolinyl , triazolyl, triazolinyl, triazolidinyl , tetrazolyl, tetrazoliny
  • heterocyclic groups include those substituted at any substitutable position with an oxo or thioketone group.
  • heterocyclics mentioned above may optionally be further substituted.
  • substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5) .
  • substituents in "substituted” include: but are not particularly limited to, halogen, nitro, cyano, hydroxyl, formyl, C 1 -C 12 alkyl, C 1 -C 12 haloalkyl, C 1 -C 12 alkoxy, C 1 -C 12 haloalkoxy, C 1 -C 12 alkoxy C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy C 1 -C 12 alkyl, C 3 -C 12 cycloalkyl, C 3 -C 12 cycloalkyl C 1 -C 12 alkyl, C 1 -C 12 alkylcarbonyl , C 1 -C 12 haloalkylcarbonyl , arylcarbonyl , aryloxycarbonyl , C 1 -C 12 alkoxycarbonyl , C 1 -C 12 haloalkoxycarbonyl , C 1 -C 12 cyan
  • substituents are halogen, nitro, cyano, Ci-Ci 2 alkyl, 0 2 -0i 2 haloalkyl, 0 2 -0i 2 alkoxy, 0 2 -0i 2 haloalkoxy, 0 2 -0i 2 alkylsulfonyl, Ci-Ci 2 alkoxycarbonyl , Ci-Ci 2 haloalkylsulfonyl, Ci-Ci 2 alkylsulfinyl, 0 2 -0i 2 haloalkylsulfinyl, 0 2 -0i 2 alkylthio, Ci-Ci 2 haloalkylthio, substituted or unsubstituted amino, aryl, and heterocyclic, and more preferable substituents are fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, C(CH 3 ) 3 trifluoromethyl
  • Preferable substituted aryl groups are halogen-substituted aryl, dihalogen-substituted aryl, Ci-Ci 2 alkyl-substituted aryl, Ci-Ci 2 haloalkyl-substituted aryl, halogen and Ci-Ci 2 haloalkyl-substituted aryl, Ci-Ci 2 alkoxy-substituted aryl, Ci-Ci 2 haloalkoxy-substituted aryl, and Ci-Ci 2 alkylthio-substituted aryl .
  • More preferable substituted aryl groups are chlorine-substituted aryl, dichlorine-substituted aryl, fluorine-substituted aryl, difluorine-substituted aryl, trifluoromethyl-substituted aryl, methyl-substituted aryl, chlorine- and trifluoromethyl-substituted aryl, trifluoromethoxy-substituted aryl, methoxy-substituted aryl, trifluoromethoxy-substituted aryl, and methylthio-substituted aryl.
  • Preferable substituted heteroaryl groups are halogen-substituted heteroaryl, Ci-Ci 2 alkyl-substituted heteroaryl, Ci-Ci 2 haloalkyl-substituted heteroaryl, halogen and Ci-Ci 2 haloalkyl-substituted heteroaryl, Ci-Ci 2 alkoxy-substituted heteroaryl, Ci-Ci 2 haloalkoxy-substituted heteroaryl, and Ci-Ci 2 alkylthio-substituted heteroaryl.
  • More preferable substituted heteroaryl groups are chlorine-substituted heteroaryl, fluorine-substituted heteroaryl, trifluoromethyl-substituted heteroaryl, chlorine- and trifluoromethyl-substituted heteroaryl, trifluoromethoxy-substituted heteroaryl, and methoxy-substituted heteroaryl, and methylthio-substituted heteroaryl.
  • Preferable substituted heterocyclic groups are halogen-substituted heterocyclic, C 1 -C 12 alkyl-substituted heterocyclic, C 1 -C 12 haloalkyl-substituted heterocyclic, C 1 -C 12 alkoxy-substituted heterocyclic, C 1 -C 12 haloalkoxy-substituted heterocyclic, and C 1 -C 12 alkylthio-substituted heterocyclic.
  • More preferable substituted heterocyclic groups are chlorine-substituted heterocyclic, fluorine-substituted heterocyclic, trifluoromethyl-substituted heterocyclic, trifluoromethoxy-substituted heterocyclic, methoxy-substituted heterocyclic, and methylthio-substituted heterocyclic.
  • the salts of the compounds represented by Formula (1) may be any type of salts as long as they are agriculturally acceptable.
  • the salts include inorganic acid salts, such as a hydrochloride salt, a sulfate salt, a nitrate salt, and the like; organic acid salts, such as an acetate salt, a methanesulfonic acid salt, and the like; alkali metal salts, such as a sodium salt, a potassium salt, and the like; alkaline earth metal salts, such as a magnesium salt, a calcium salt, and the like; quaternary ammonium salts, such as dimethylammonium, triethylammonium, and the like; and the like.
  • Xi represents C-Rs or N
  • X 2 represents C-R 9 or N
  • X 3 represents C-R 10 or N.
  • Xi represents a nitrogen atom
  • X 2 and X 3 represent C-R 9 and C-R 10 , respectively
  • X 2 represents a nitrogen atom
  • Xi and X 3 represent C-Rs and C-R 10 , respectively
  • X 3 represents a nitrogen atom
  • X 2 and X 2 represent C-Rs and C-Rg, respectively .
  • a preferable compound is a compound in which Q represents an oxygen atom, or a sulfur atom
  • a more preferable compound (1) is a compound in which Q represents an oxygen atom
  • a preferable compound is a compound in which R. 6 and R 7 each independently represent hydrogen, halogen, or C1-C12 alkyl, and a more preferable compound (1) is a compound in which R 6 and R 7 each independently represent hydrogen, chlorine, or methyl.
  • a preferable compound is a compound in which R represents substituted or unsubstituted aryl or C1-C12 alkyl
  • a more preferable compound (1) is a compound in which R represents halogen, alkyl, haloalkyl, alkoxy, or haloalkoxy-substituted aryl, unsubstituted aryl or methyl .
  • a preferable compound is a compound in which R 2 represents hydrogen, substituted or unsubstituted C 2 -Ci 2 alkenyl, substituted or unsubstituted C 2 -Ci 2 alkynyl, substituted or unsubstituted Ci-Ci 2 alkylcarbonyl , substituted or unsubstituted C 3 -Ci 2 cycloalkylcarbonyl , substituted or unsubstituted Ci-Ci 2 alkoxycarbonyl , substituted or unsubstituted aryloxycarbonyl , or substituted or unsubstituted arylcarbonyl , and a more preferable compound (1) is a compound in which Ri represents hydrogen, unsubstituted C 2 -Ci 2 alkenyl, unsubstituted C 2 -Ci 2 alkynyl, unsubstituted Ci-Ci 2 alkylcarbonyl, unsubstituted C
  • a preferable compound is a compound in which R 2 represents hydrogen, substituted or unsubstituted Ci-Ci 2 alkyl, and a more preferable compound (1) is a compound in which R 2 represents hydrogen, methyl or ethyl.
  • a preferable compound is a compound in which R 3 represents substituted or unsubstituted Ci-Ci 2 alkyl, and a more preferable compound (1) is a compound in which R 3 represents methyl, ethyl or tri fluoromethyl .
  • a preferable compound is a compound in which R 4 and R 5 each independently represent hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, and a more preferable compound (1) is a compound in which R 4 and R 5 each independently represent hydrogen or methyl .
  • a preferable compound is a compound in which X lf X 2 and X 3 each independently represent C-R 8 , C-Rg , C-R 10 , or N
  • a more preferable compound (1) is a compound in which X 4 , X 2 and X 3 each independently represent C-R 8 , C-Rg , and C-R 10 .
  • X 4 represents a nitrogen atom
  • X 2 and X 3 represent C-Rg and C-R 10 , respectively.
  • X 4 and X 3 represent C-Rs and C-R 10 , respectively.
  • X 3 represents a nitrogen atom
  • X 4 and X 2 represent C-Rs and C-Rg , respectively .
  • a preferable compound is a compound in which R 8 , Rg and Rio each independently represent hydrogen, halogen, substituted or unsubstituted Ci-Ci 2 alkyl, and a more preferable compound (1) is a compound in which Re , Rg and Rio represent independently of each other hydrogen, chloro, methyl or ethyl .
  • a more preferable compound of the present disclosure is a compound or a salt thereof in which
  • Q represents an oxygen atom
  • R is halogen-, alkyl-, haloalkyl-, alkoxy-, or haloalkoxy-substituted aryl; unsubstituted aryl; or methyl;
  • Ri is hydrogen, unsubstituted C 2 -Ci 2 alkenyl, unsubstituted C 2 -Ci 2 alkynyl, unsubstituted Ci-Ci 2 alkylcarbonyl , unsubstituted C 3 -Ci 2 cycloalkylcarbonyl , substituted or unsubstituted Ci-Ci 2 alkoxycarbonyl , unsubstituted aryloxycarbonyl , or substituted or unsubstituted arylcarbonyl ;
  • R 2 is hydrogen, or substituted or unsubstituted Ci-Ci 2 alkyl
  • R 3 is substituted or unsubstituted Ci-Ci 2 alkyl
  • R 4 is hydrogen, or substituted or unsubstituted Ci-Ci 2 alkyl
  • R 5 is hydrogen or methyl
  • Xi represents C-R 8 or N
  • X 2 represents C-Rg ;
  • X 3 represents C-Rio;
  • Rs is hydrogen, C 1 -C 12 alkyl or halogen
  • R 9 is hydrogen, C 1 -C 12 alkyl or halogen
  • Rio is hydrogen, C 1 -C 12 alkyl or halogen.
  • a particularly preferable compound of the present disclosure is a compound or a salt thereof in which
  • Q represents an oxygen atom
  • Rg is hydrogen
  • R 7 is hydrogen
  • R is substituted or unsubstituted aryl, or C 1 -C 12 alkyl
  • Ri is hydrogen, unsubstituted C 2 -Ci 2 alkenyl, unsubstituted C 2 -Ci 2 alkynyl, unsubstituted Ci-Ci 2 alkylcarbonyl , unsubstituted C 3 -Ci 2 cycloalkylcarbonyl , substituted or unsubstituted Ci-Ci 2 alkoxycarbonyl , unsubstituted aryloxycarbonyl , or substituted or unsubstituted arylcarbonyl;
  • R 2 is hydrogen, methyl or ethyl
  • R 3 is methyl, ethyl or trifluoromethyl ;
  • R 4 is hydrogen or methyl
  • R 5 is hydrogen, or substituted or unsubstituted Ci-Ci 2 alkyl
  • X 2 represents C-R 3 or N
  • X 2 represents C-R 9 ;
  • X 3 represents C-Rio
  • R is hydrogen, chloro, methyl or ethyl
  • R 9 is hydrogen, chloro, methyl or ethyl
  • Rio is hydrogen, chloro, methyl or ethyl.
  • Another more preferable compound of the present disclosure is a compound or a salt thereof in which
  • Q represents an oxygen atom or a sulfur atom, preferably an oxygen atom
  • R is Cg aryl substituted with halogen, Ci-Cg alkyl, Ci-Cg haloalkyl, Ci-Cg alkoxy, Ci-Cg haloalkoxy, and/or Ci-Cg haloalkylsulfonyl ;
  • Ri is hydrogen, unsubstituted Ci-Cg alkoxycarbonyl, unsubstituted Ci-Cg alkylcarbonyl, unsubstituted Ci-Cg haloalkylcarbonyl , unsubstituted C 3 -Cg cycloalkylcarbonyl, or unsubstituted Cg arylcarbonyl, or Ci-Cg haloalkyl-substituted Cg arylcarbonyl;
  • R 2 is Ci-C 3 alkyl
  • R 3 is hydrogen or Ci-C 3 alkyl
  • R. 4 is hydrogen or C 1 -C 3 alkyl
  • R 5 is hydrogen or C 1 -C 3 alkyl
  • Xi represents C-Rs
  • X 2 represents C-Rg
  • X 3 represents C-Ri 0 ;
  • R 8 is hydrogen, C 1 -C 3 alkyl, or fluorine
  • Rg is hydrogen or C 1 -C 3 alkyl
  • Rio is hydrogen or C 1 -C 3 alkyl.
  • a particularly preferable compound of the present disclosure is a compound or a salt thereof in which
  • Q represents an oxygen atom or a sulfur atom, preferably an oxygen atom
  • R is Ce aryl substituted with fluorine, chlorine, bromine, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, and/or C 1 -C 3 haloalkoxy;
  • Ri is hydrogen, unsubstituted Ci-C 6 alkoxycarbonyl , unsubstituted Ci-C 6 alkylcarbonyl , unsubstituted Ci-C 6 haloalkylcarbonyl , or unsubstituted cyclopropylcarbonyl ;
  • R 2 is methyl
  • R 3 is ethyl
  • R 4 is hydrogen, methyl, or ethyl
  • R 5 is hydrogen, methyl, or ethyl
  • Xi represents C-Rs
  • X 2 represents C-Rg
  • X 3 represents C-R 10 ;
  • Rs is hydrogen, methyl, or ethyl
  • Rg is methyl
  • the present disclosure also incorporates preparation of the said novel substituted pyrazole compounds or a salt thereof as represented by formula (1) .
  • preparation of the compounds of the present disclosure There are various known synthesis procedures for the preparation of the compounds of the present disclosure. Hereinafter, the synthesis procedure for one type of compounds of the present disclosure will be described and shown in Scheme- 1 . However, the preparation of the novel substituted pyrazole compounds or a salt thereof is not limited to this method.
  • R, Ri, R 2 , R3, Xi, X 2 , X3 and Q are as defined above while LG and LGi are any of known leaving groups.
  • This step provides a method of preparing compound (III) by the reaction of compound with compound (II)
  • R is as defined above.
  • the aforementioned reaction is performed in an appropriate solvent or without any solvent.
  • a solvent include: fatty acid or alicyclic hydrocarbon-based solvents, such as n-hexane, cyclohexane, n-heptane, and the like; aromatic hydrocarbon-based solvents, such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents, such as methylene chloride, 1 , 2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ester solvents, such as diethyl ether, tetrahydrofuran (THF) , 1,4-dioxane, and the like; amide-based solvents, such as acetonitrile; A/,A/-
  • the amount of the solvent to be used is usually 0.5 to 20 liters, preferably 0.5 to 10 liters, per 1 mol of the compound (I) .
  • the amount of compound (II) to be used is usually 1.0 to 10.0 mol, preferably 1.0 to 1.5 mol, per 1 mol of the compound (I) .
  • the reaction temperature varies depending on the starting compound, the reagent, the solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 100°C.
  • the reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is usually from 10 minutes to 48 hours, preferably from 60 minutes to 10 hours.
  • R is as defined above.
  • Formylation can be done by any known procedures. Some examples of the formylation include, but are not limited to, using POCI 3 -DMF system or using hexamethylenetetramine.
  • the aforementioned reaction is performed in an appropriate solvent or without any solvent. When the aforementioned reaction is carried out in the solvent, no limitations are placed on the solvent as long as the solvent is inactive with respect to the aforementioned reaction.
  • a solvent examples include: halogenated hydrocarbon-based solvents, such as methylene chloride, 1 , 2-dichloroethane, chloroform, carbon tetrachloride, and the like; ether-based solvents, such as tetrahydrofuran (THF), 1,4-dioxane, and the like; ester solvents, such as methyl acetate, ethyl acetate, and the like; amide-based solvents, such as acetonitrile; A/,A/-dimethylformamide (DMF) , A/,A/-dimethylacetamide, A/-methyl-2-pyrolidone and the like; and trifluoroacetic acid, dimethyl sulfoxide, sulfolane, etc. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary.
  • halogenated hydrocarbon-based solvents such as methylene chloride, 1 , 2-dichlor
  • the amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters, per 1 mol of the compound (III) .
  • the amount of phosphorous oxychloride to be used is usually 1.0 to 20.0 mol , preferably 1.0 to 10.0 mol , per 1 mol of the compound
  • the amount of hexamethylenetetramine to be used is usually 1.0 to 10.0 mol, preferably 1.0 to 5.0 mol, per 1 mol of the compound (III) .
  • the reaction temperature varies depending on the starting compound, the reaction reagent, the solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 50 to 120°C.
  • the reaction time varies depending on the compound, the reaction reagent, the solvent and the reaction temperature and the like, but is usually from 10 minutes to 48 hours, preferably from 1 to 10 hours.
  • This step consists of two phases.
  • R and Q is as defined above.
  • any known peracid can be used, examples include but are not limited to, m-chloroperbenzoic acid, hydrogen peroxide, peracetic acid, etc.
  • the amount of the peracid is usually 1.0 to 20.0 mol, preferably 1.0 to 5.0 mol, per 1 mol of the compound (IV) .
  • the aforementioned reaction is performed in an appropriate solvent or without any solvent.
  • a solvent include: halogenated hydrocarbon-based solvents, such as methylene chloride, 1 , 2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether-based solvents, such as tetrahydrofuran (THF) , 1,4-dioxane, and the like; ester solvents, such as methyl acetate, ethyl acetate, and the like; amide-based solvents, such as acetonitrile; A/,A/-dimethylformamide (DMF) , A/,A/-dimethylacetamide, A/-methyl-2-pyrolidone and the like; and dimethyl sulfoxide and sulfolane. Any one of these solvents
  • the amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters, per 1 mol of the compound (IV) .
  • the hydrolysis of the intermediate can be done by any known procedure, examples include, but are not limited to, using an acid in protic solvents, or using a base in appropriate solvent.
  • any well-known acid like hydrochloric acid, sulfuric acid, etc. can be used while in basic conditions, any known base, such as organic bases like triethylamine or inorganic bases like sodium hydroxide can be used.
  • the amount of the acid or base to be used is usually 1.0 to 20.0 mol, preferably 1.0 to 5.0 mol, per 1 mol of the compound (IV) .
  • the aforementioned reaction is performed in an appropriate solvent or without any solvent.
  • a solvent include: halogenated hydrocarbon-based solvents, such as methylene chloride, 1 , 2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether-based solvents, such as tetrahydrofuran (THF) , 1,4-dioxane, and the like; ester solvents, such as methyl acetate, ethyl acetate, and the like; amide-based solvents, such as acetonitrile; A/,A/-dimethylformamide (DMF) , A/,A/-dimethylacetamide, A/-methyl-2-pyrolidone and the like; dimethyl sulfoxide or sulfolane; and protic solvents like
  • the amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters, per 1 mol of the compound (IV) .
  • the reaction temperature varies depending on the starting compound, the reagent, the solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 100°C.
  • the reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is usually from 10 minutes to 48 hours, preferably from 6 hours to 18 hours.
  • This step consists of reactions between compound (V) and compound (VI) in the presence of a base and solvent to produce the compound (VII) .
  • LG represents any suitable leaving group, such as halogen, O-mesylates, O-sulfonates, O-tosylates, etc.
  • the base used for the above mentioned reaction is not particularly limited.
  • any conventionally known base can widely be used, and examples of the base include: alkali metal carbonates, such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; alkali metal hydroxides, such as sodium hydroxide, potassium hydroxide, and the like; inorganic bases including alkali metal hydrides, such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides, such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, and the like; organic bases, such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine, and the like. Any separate one of these bases or a combination of two or more types thereof can be used.
  • the amount of the base to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 1.5 mol, per 1 mol of the compound (V) .
  • the aforementioned reaction is performed in an appropriate solvent. No limitations are placed on the solvent as long as the solvent is inactive with respect to the aforementioned reaction.
  • a solvent examples include: halogenated hydrocarbon-based solvents, such as methylene chloride, 1 , 2-dichloroethane, chloroform, and carbon tetrachloride, and the like; amide-based solvents, such as tetrahydrofuran (THF) , 1,4-dioxane; acetonitrile; N, N-dimethylformamide (DMF) , N, N-dimethylacetamide, A/-methyl-2-pyrolidone and the like; and dimethyl sulfoxide, sulfolane, and protic solvents, such as methanol, ethanol, water, etc. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary.
  • halogenated hydrocarbon-based solvents such as methylene chloride, 1 , 2-dichloroethane, chloroform, and carbon tetrachloride, and the like
  • amide-based solvents such
  • the amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters, per 1 mol of the compound (V) .
  • the reaction temperature varies depending on the starting compound, the reaction reagent, the solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 100°C.
  • the reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is usually from 10 minutes to 48 hours, preferably from 60 minutes to 12 hours.
  • This step involves the reduction of nitro group (N0 2 ) present in the compound (VII) to produce amino group (NH 2 ) of the compound (VIII) .
  • R, Xi, X 2 , X3 and Q are as defined above.
  • the reaction temperature varies depending on the starting compound, the reagent, the solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 90°C.
  • the reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is usually from 5 minutes to 48 hours, preferably from 60 minutes to 6 hours.
  • This step is a method of preparing the compound (X) from the reactions of compound (VIII) and compound (IX) in the presence of a catalyst and a suitable solvent.
  • R, R 2 , R 3 , Xi, X 2 , X 3 and Q are as defined above.
  • the aforementioned reaction is performed in an appropriate solvent or without any solvent.
  • a solvent include: benzene, chlorobenzene, toluene, xylene, 1 , 2-dichloroethane, diphenyl ether, acetonitrile, A/,A/-dimethylformamide (DMF) , A/,A/-dimethylacetamide, A/-methyl-2-pyrolidone, polyphosphoric acid Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary.
  • the amount of the solvent to be used is usually 0.5 to 20 liters, preferably 0.5 to 10 liters, per 1 mol of the compound represented by formula (VIII) .
  • the aforementioned reaction can be performed under the presence of a catalyst.
  • a catalyst there are various conventional catalysts which can be used for this reaction and some examples of these catalysts include: trifluoroacetic acid; hydrochloric acid; sulfuric acid; p-toluene sulfonic acid; boron trifluoride etherate (BF 3 -Et 2 0) ; aluminium chloride (AICI 3 ) ; iron chloride (FeCls); titanium chloride (T ⁇ 01 4 ) ; tin chloride (SnCl 4 ) .
  • the amount of the acid to be used is usually 1.0 to 5 mol, preferably 0.05 mol, per 1.5 mol of the compound (VIII) .
  • the amount of the acetoacetate (IX) to be used is usually 1.0 to 10.0 mol, preferably 1.0 to 5.0 mol of the compound (VIII) .
  • the reaction temperature varies depending on the type of the starting compound, the reagent, and the solvent and generally from 0°C to 200 0 C .
  • the reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is usually from 10 minutes to 48 hours, preferably from 2 hours to 16 hours.
  • This step produces the compound ( 1 ) by the treatment of compound (X) with compound (XI) .
  • R, Ri, R 2 , R 3 , Rg, Rio, Xi, X 2 , X 3 and Q are as defined above.
  • LGi represents any suitable leaving group, such as halogen, O-mesylates, O-sulfonates, O-tosylates, etc.
  • the aforementioned reaction is performed in an appropriate solvent or without any solvent.
  • a solvent include: aromatic hydrocarbon-based solvents, such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents, such as methylene chloride, 1 , 2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether-based solvents, such as diethyl ether, tetrahydrofuran (THF) , 1,4-dioxane, and the like; ester solvents, such as methyl acetate, ethyl acetate, and the like s; amide-based solvents, such as acetonitrile; A/,A/-dimethylformamide (DMF) ,
  • aromatic hydrocarbon-based solvents such as benzene, chlorobenzene, toluene, xylene, and the like
  • A/,A/-dimethylacetamide, A/-methyl-2-pyrolidone and the like and ketone-based solvents, such as acetone, methyl ethyl ketone, cyclohexanone, and the like; and dimethyl sulfoxide. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary.
  • the amount of the solvent to be used is usually 0.5 to 20 liters, preferably 0.5 to 10 liters, per 1 mol of the compound represented by formula (X) .
  • a base used for the above mentioned reaction is not particularly limited.
  • a conventionally known base can widely be used, and examples of the base include: alkali metal carbonates, such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; metal hydroxides, such as sodium hydroxide, potassium hydroxide, and the like alkali; inorganic bases including alkali metal hydrides, such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides, such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, and the like; organic bases, such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine, and the like; and preferably pyridine. Any separate one of these bases or a combination of two or more types
  • the amount of the base to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 1.1 mol, per 1 mol of the compound (X) , sometimes, when an organic base is used it can serve as a solvent also.
  • the amount of compound (XI) to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 2.0 mol, per 1 mol of the compound (X) .
  • the reaction temperature varies depending on the starting compound, the reagent, the solvent and the like, but it is generally from — 10 ° C to boiling point of the solvent.
  • the reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is usually from 10 minutes to 48 hours, preferably from 1 hour to 12 hours.
  • Each compound represented in Scheme- 1 after the completion of the reaction can be easily isolated from the reaction mixtures and purified by known isolations and purification techniques, such as filtration, solvent extraction, distillation, recrystallization, and column chromatography.
  • Compound (1) of the present disclosure may be used as an active ingredient of a pest-controlling agent.
  • pest-controlling agents include agents (agricultural and horticultural insecticide, miticides, nematicides, or soil insecticides) for controlling pests , mites, nematode, or soil pests that all cause problems in the agricultural and horticultural fields; animal-ectoparasite-controlling agents (e.g., pulicide, ixodicide, and pedivulicide) , and the like.
  • compound (1) of the present disclosure For use as an active ingredient of a pest-controlling agent, it is possible to use compound (1) of the present disclosure as is with no additional components. However, it is usually preferable to use the compound by it combining with a solid carrier, liquid carrier, or gaseous carrier (propellant) , and optionally with a surfactant and other adjuvants for pharmaceutical preparation, and formulating the resulting mixture into various forms, such as oil solutions, emulsions, wettable powders, flowable preparations, granules, dusts, aerosols, fumigants, or the like, according to known preparation methods.
  • a solid carrier liquid carrier, or gaseous carrier (propellant)
  • surfactant and other adjuvants for pharmaceutical preparation, and formulating the resulting mixture into various forms, such as oil solutions, emulsions, wettable powders, flowable preparations, granules, dusts, aerosols, fumigants, or the like, according to known preparation methods.
  • Compound (1) of the present disclosure is usually contained in these formulations in a proportion of 0.01 to 95 wt%, and preferably 0.1 to 50 wt% .
  • solid carrier examples include mineral carriers, such as pyrophyllite clay, kaolin clay, silicastone clay, talc, diatomaceous earth, zeolite, bentonite, acid clay, active clay, Attapulgus clay, vermiculite, perlite, pumice, white carbon (e.g., mineral carriers, such as pyrophyllite clay, kaolin clay, silicastone clay, talc, diatomaceous earth, zeolite, bentonite, acid clay, active clay, Attapulgus clay, vermiculite, perlite, pumice, white carbon (e.g.
  • mineral carriers such as pyrophyllite clay, kaolin clay, silicastone clay, talc, diatomaceous earth, zeolite, bentonite, acid clay, active clay, Attapulgus clay, vermiculite, perlite, pumice, white carbon (e.g.
  • synthetic silicic acid or synthetic silicate titanium dioxide and the like
  • vegetable carriers such as wood flour, corn culm, walnut shell, fruit stone, rice hull, sawdust, wheat bran, soybean flour, powder cellulose, starch, dextrin, saccharide and the like
  • inorganic salt carriers such as calcium carbonate, ammonium sulfate, sodium sulfate, potassium chloride and the like
  • polymer carriers such as polyethylene, polypropylene, polyvinyl chloride, polyvinyl acetate, ethylene-vinyl acetate copolymer, urea-aldehyde resin and the like.
  • liquid carrier examples include monohydric alcohols, such as methanol, ethanol, propanol, isopropanol, butanol, cyclohexanol and the like; polyhydric alcohols, such as ethylene glycol, diethylene glycol, propylene glycol, hexylene glycol, polyethylene glycol, polypropylene glycol, glycerine and the like; polyhydric alcohol derivatives, such as propylene type glycol ether and the like; ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone, diisobutyl ketone, cyclohexanone, isophorone and the like; ethers, such as ethyl ether, 1,4-dioxane, cellosolve, dipropyl ether, tetrahydrofuran and the like; aliphatic hydrocarbons, such as normal paraffin, naphthene, isoparaffin, ali
  • the surfactant preferably gels or swells in water.
  • non-ionic surfactants such as sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene resin acid ester, polyoxyethylene fatty acid diester, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene dialkylphenyl ether, polyoxyethylene alkylphenyl ether-formalin condensate, polyoxyethylene polyoxypropylene block polymer, alkyl polyoxyethylene polypropylene block polymer ether, polyoxyethylene alkyl amine, polyoxyethylene fatty acid amide, polyoxyethylene fatty acid bisphenyl ether, polyalkylene benzyl phenyl ether, polyoxyalkylene styryl phenyl ether, acetylene diol, polyoxyethylene fatty acid bisphenyl ether, polyalkylene
  • dialkyldiaminoethylbetaine or alkyldimethylbenzylbetaine amino acid type (e.g. dialkylaminoethylglycine or alkyldimethylbenzylglycine ) and the like .
  • binder and the tackifier examples include carboxymethyl cellulose or a salt thereof, dextrin, water-soluble starch, xanthane gum, guar gum, sucrose, polyvinylpyrrolidone, gum arabic, polyvinyl alcohol, polyvinyl acetate, sodium polyacrylate, polyethylene glycol having an average molecular weight of 6, 000 to 20,000, polyethylene oxide having an average molecular weight of 100,000 to 5,000,000, and natural phospholipid (e.g. cephalinic acid or lecithin) .
  • phospholipid e.g. cephalinic acid or lecithin
  • examples include water-soluble polymers, such as xanthan gum, guar gum, carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, starch derivative, polysaccharide and the like; and inorganic fine powders, such as high-purity bentonite, white carbon and the like.
  • water-soluble polymers such as xanthan gum, guar gum, carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, starch derivative, polysaccharide and the like
  • inorganic fine powders such as high-purity bentonite, white carbon and the like.
  • examples include, inorganic pigments, such as iron oxide, titanium oxide, Prussian Blue and the like; and organic dyes, such as Alizarine dye, azo dye, metal phthalocyanine dye and the like.
  • examples include silicone-based surfactant, cellulose powder, dextrin, processed starch, polyaminocarboxylic acid chelate compound, crosslinked polyvinylpyrrolidone, maleic acid and styrene, methacrylic acid copolymer, half ester between polyhydric alcohol polymer and dicarboxylic acid anhydride, and water-soluble salt of polystyrenesulfonic acid.
  • examples include surfactant (e.g. sodium dialkylsulfosuccinate, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, or polyoxyethylene fatty acid ester) , paraffin, terpene, polyamide resin, polyacrylic acid salt, polyoxyethylene, wax, polyvinyl alkyl ether, alkylphenol-formalin condensate, and synthetic resin emulsion.
  • surfactant e.g. sodium dialkylsulfosuccinate, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, or polyoxyethylene fatty acid ester
  • paraffin terpene
  • polyamide resin polyacrylic acid salt
  • polyoxyethylene wax
  • polyvinyl alkyl ether polyvinyl alkyl ether
  • alkylphenol-formalin condensate alkylphenol-formalin condensate
  • examples include polyhydric alcohol (e.g. ethylene glycol, diethylene glycol, propylene glycol, or glycerine) .
  • polyhydric alcohol e.g. ethylene glycol, diethylene glycol, propylene glycol, or glycerine
  • examples include polysaccharide (e.g. starch, alginic acid, mannonse or galactose), polyvinylpyrrolidone, white carbon, ester gum and petroleum resin.
  • polysaccharide e.g. starch, alginic acid, mannonse or galactose
  • polyvinylpyrrolidone e.g. white carbon, ester gum and petroleum resin.
  • examples include sodium tripolyphosphate, sodium hexametaphosphate, stearic acid metal salt, cellulose powder, dextrin, methacrylic acid ester copolymer, polyvinylpyrrolidone, polyaminocarboxylic acid chelate compound, sulfonated styrene-isobutylene-maleic anhydride copolymer, and starchpolyacrylonitrile graft copolymer.
  • examples include, desiccants, such as zeolite, quick lime, magnesium oxide and the like; antioxidants, such as phenol type, amine type, sulfur type, phosphoric acid type and the like; and ultraviolet absorbents, such as salicylic acid type, benzophenone type and the like.
  • the present pest control agent contains the above-mentioned additive components
  • their contents based on mass are selected in a range of ordinarily 5 to 95%, preferably 20 to 90% in the case of carrier (e.g. solid carrier or liquid carrier), ordinarily 0.1 to 30%, preferably 0.5 to 10% in the case of surfactant, and ordinarily 0.1 to 30%, preferably 0.5 to 10% in the case of other additives .
  • the present pest control agent is used in any formulation selected from dust formulation, dust-granule mixture, granule, wettable powder, water-soluble concentrate, water-dispersible granule, tablet, Jumbo, emulsifiable concentrate, oil formulation, solution, flowable concentrate, emulsion, microemulsion, suspoemulsion, ultra-low volume formulation, microcapsule, smoking agent, aerosol, baiting agent, paste, etc.
  • the formulation can be used per se or after dilution with a diluent (e.g. water) in a given concentration.
  • a diluent e.g. water
  • the application of the formulation containing the present compound or its dilution product can be conducted by a method ordinarily used, such as dispersion (e.g. spraying, misting, atomizing, powder dispersion, granule dispersion, on-water-surface dispersion, or inbox dispersion) , in-soil application (e.g. mixing or drenching), on-surface application (e.g. coating, dust coating or covering), immersion, poison bait, smoking and the like.
  • dispersion e.g. spraying, misting, atomizing, powder dispersion, granule dispersion, on-water-surface dispersion, or inbox dispersion
  • in-soil application e.g. mixing or drenching
  • on-surface application e.g. coating
  • the proportion (mass %) of the active ingredient in the present pest control agent is appropriately selected so as to meet the necessity.
  • the active ingredient is appropriately selected, for example, in the following ranges:
  • dust-granule mixture, etc. 0.01 to 20%, preferably 0.05 to 10%.
  • granule, etc. 0.1 to 30%, preferably 0.5 to 20%.
  • the formulation is sprayed after dilution in an appropriate concentration, or applied directly.
  • the concentration of active ingredient is generally 0.1 to 5, 000 ppm.
  • the application amount thereof per unit area is 0.1 to 5,000 g per 1 ha in terms of active ingredient compound; however, the application amount is not restricted thereto.
  • the present pest control agent is sufficiently effective when using the present compound alone as an active ingredient.
  • the present pest control agent may be mixed or used in combination, as necessary, with fertilizers and agricultural chemicals, such as insecticide, miticide, nematocide, synergist, fungicide, antiviral agent, attractant, herbicide, plant growth-controlling agent and the like. In this case, a higher effect is exhibited.
  • Compound (1) of the present disclosure is effectively used as an agricultural and horticultural insecticide, miticide, nematicide, or a soil insecticide.
  • compound (1) of the present disclosure is effective for controlling pests: for example, aphids, such as green peach aphids, cotton aphids, and the like; diamondback moths, Spodoptera litura, cabbage armyworms, common cutworms, codling moths, bollworms, tobacco budworms, gypsy moths, rice leafrollers, smaller tea tortrix moths , Colorado potato beetles, cucurbit leaf beetles, boll weevils, plant hoppers, leafhoppers, scales, bugs, whiteflies, thrips, grasshoppers, anthomyiid flies scarabs, black cutworms, cutworms, ants, and agricultural pest insects; gastropods, such as slugs, snails, and the like; hygiene-harming insects, such as rat mit
  • Compound (1) of the present disclosure is characterized by having a particularly excellent fungicidal activity and a broad spectrum of activity.
  • the compound may be used for controlling plant diseases ascribed to various fungal pathogens or resistant fungal pathogens.
  • fungal pathogens include those that cause cucumber gray mold, rice plant blast (Pyricularia grisea, millet) , rice plant sheath blight, apple powdery mildew, apple Alternaria blotch, persimmon powdery mildew, grape powdery mildew, barley powdery mildew, wheat powdery mildew, cucumber powdery mildew, cucumber gray mold, tomato late blight, strawberry powdery mildew, tobacco powdery mildew, and the like.
  • m-Chloroperbenzoic acid (8.34 g, 48.36 mmol, 0.9 equiv.) was added to a solution of 1- (p-tolyl ) -lff-pyrazole-4-carbaldehyde (10.0 g, 53.74 mmol, 1.0 equiv.) in chloroform (500 mL) at room temperature under nitrogen atmosphere. The resulting mixture was refluxed for 4h.
  • reaction mixture was then cooled to room temperature, diluted with DCM (100 mL) , washed with sodium bicarbonate solution (3 x 100 mL) followed by distilled water (3 x 100 mL) , dried over sodium sulfate, filtered and concentrated under reduced pressure to give a crude product .
  • the pH of the reaction mixture was then made neutral by adding sodium bicarbonate solution and extracted with ethyl acetate (3 x 100 mL) .
  • CCbMe methoxycarbonyl , C0 2 Et: ethoxycarbonyl , CC ⁇ Ph: phenoxycarbonyl , Cy-pr: cyclopropyl, Cy-pent : cyclopentyl, F 2 -Ph: difluorophenyl, Cl 2 -Ph: dichlorophenyl , Cl 3 -Ph: trichlorophenyl , S0 2 Me: methylsulfonyl, SC ⁇ Et: ethylsulfonyl, SO 2 CF 3 : trifluoromethylsulfonyl, CN : cyano, N0 2 : nitro.
  • each compound of the present disclosure was added to a mixture of 2 parts of sodium lauryl sulfate, 4 parts of sodium lignin sulfonate, 20 parts of fine powder of synthetic hydrated silicon dioxide, and 54 parts of clay.
  • the mixtures were mixed by blending in a juice mixer to give 20% wettable powders.
  • each compound of the present disclosure was mixed with 20 parts of water containing 3 parts of polyoxyethylene tristyrylphenyl ether phosphoric acid ester triethanolamine and 0.2 parts of Rhodorsil 426R.
  • the mixtures were subjected to wet pulverization with a DYNO-Mill, and mixed with 60 parts of water containing 8 parts of propylene glycol and 0.32 parts of xanthan gum to give 20% suspensions in water.
  • Compound A, Compound B and Flometoquin are the representative compounds mentioned in the specification of W02006/013896A1, W02007/088978A1.
  • Test Example 1 (Aphicidal test on Cotton aphid)
  • Apiece of non-woven fabric (4.5 x 5.5 cm) was suspended inside a plastic cup through an incision made in the lid of the plastic cup. After water was poured into the cup, the cup was covered with the lid.
  • a cucumber leaf (about 3.5 x 4.5 cm) was then placed on the sufficiently soaked, non-woven fabric.
  • Another cucumber leaf with cotton aphid (about 30 aphid samples) was placed on top of the first leaf, and the fabric and leaves were placed in a thermostatic chamber having a temperature of 25 ⁇ 2°C and a humidity of 40% for overnight. Next morning the top leaf was removed as aphid population has already moved to lower leaf.
  • Insecticidal formulations containing the compound of the present disclosure were prepared by adding an aqueous solution (100 ppm) of Sorpol 355 (manufactured by TOHO Chemical Industry Co., Ltd.) to a methanol solution of the compound of the present disclosure.
  • Insecticidal formulations were sprayed onto the leaves, and the leaves were air-dried and placed in a thermostatic chamber (25 ⁇ 2°C and a humidity of 50%) .
  • the mortality rate of the cotton aphid was calculated after 3 days.
  • Insecticidal formulations containing the compound of the present disclosure prepared in the same manner as in test example 1. These Insecticidal formulations were sprayed onto the castor leaves (4 x 4 cm) , leaves were air-dried and placed in a plastic cup over moist paper . 4 days old Spodoptera larvae (12-15 Nos.) were released, and cup is closed and placed in a thermostatic chamber (25 ⁇ 2°C and a humidity of 50%) . The mortality rate of the spodoptera was calculated after 3 days.
  • Apiece of non-woven fabric (4.5 x 5.5 cm) was suspended inside a plastic cup through an incision made in the lid of the plastic cup. After water was poured into the cup, the cup was covered with the lid.
  • a kidney bean leaf (about 3.5 x 4.5 cm) was then placed on the sufficiently soaked, non-woven fabric.
  • Another kidney bean leaf with two-spotted spider mites (about 30 mite samples) was placed on top of the first leaf, and the fabric and leaves were placed in a thermostatic chamber having a temperature of 25 ⁇ 2°C and a humidity of 40% overnight. Next morning the top leaf was removed as the mite population had already moved to the lower leaf.
  • Miticidal formulations containing the compound of the present disclosure prepared in the same manner as in test example 1. These miticidal formulations were sprayed onto the leaves, and the leaves were air-dried and placed in a thermostatic chamber (25 ⁇ 2°C and a humidity of 50%) . The mortality rate of the two-spotted spider mites was calculated after 2 days.
  • Apiece of non-woven fabric (4.5 x 5.5 cm) was suspended inside a plastic cup through an incision made in the lid of the plastic cup. After water was poured into the cup, the cup was covered with the lid. A kidney bean leaf (about 3.5 x 4.5 cm) was then placed on the sufficiently soaked, non-woven fabric. Twenty female adults of two-spotted spider mite were placed on the top of the leaf, and the fabric and leaf were placed in a thermostatic chamber having a temperature of 25 ⁇ 2°C and a humidity of 40% and 16L8D.
  • Miticidal formulations containing the compound of the present disclosure 500 ppm and 100 ppm prepared in the same manner as in test example 1 was sprayed onto the leaf, and the leaf was air-dried and placed in a thermostatic chamber (25 ⁇ 2°C and a humidity of 50%) .
  • the ovicidal rate of the two-spotted spider mites was calculated 6 days after the spraying of the miticidal formulation.
  • Compounds IB-38, IB-39, IB-41, IB-46, IB-47, IB-59, IB-61, IB-62, IB-63 , IB-64 , IB-66, IB-69, IB-70, IB-73, IB-75, IB-78 and IB-83 showed 80% or more mortality at 100 ppm whereas the reference compounds Compound A showed 40% mortality at 500 ppm and 0% mortality at 100 ppm, and the reference Compound B and Flometoquin each showed less than 30% mortality at 500 ppm.
  • Test example 5 Fungicidal test on Pyricularia grisea, millet
  • the small bit of mycelium of Pyricularia grisea was taken from culture tube and transferred on mathur media plate aseptically .
  • the inoculated plate was kept for 7 days at 25°C.
  • plates were incubated at 25°C for 5 days under the exposure to black light blue, 16L8D.
  • After five days the plates were fully covered with spores of fungus.
  • the spores were washed from plate with 0.01% Tween 20 solution and were passed through tissue paper. Then the filtrate was diluted with the 0.01% Tween 20 solution to obtain 2 x 10 5 cfu spore per ml .
  • the solution of the compound of the present disclosure (500 ppm) prepared in the same manner as in test example 1 was sprayed on fresh healthy two weeks old millet plants.
  • the plants were air-dried and inoculated with freshly prepared spore suspension.
  • the inoculated plants were then placed in a dew chamber (25°C and a humidity of 100%) .
  • One day after inoculation the plants were shifted to thermostatic chamber (25°C, a humidity of 80% , andl6L8D) .
  • the percent disease control was assessed after 5-7 days from leaf disease area compared to control.
  • Compounds 1A-276, 1A-325, IB-7 and IB-33 showed 80% or more control whereas the reference compounds (Compound A, Compound B and Flometoquin) showed less than 50%, less than 30%, and less than 30% control at 500 ppm, respectively.
  • Test example 6 Fungicidal test on Sphaerotheca fullglnea , cucumber
  • Sphaerotheca fuliginea was cultured on intact cucumber plants . Infected leaves with spores were washed with 0.01% Tween 20 solution and were passed through tissue paper. Then the filtrate was diluted with the 0.01% Tween 20 solution to obtain 2 x 10 5 cfu spore per ml .
  • the solution of the compound of the present disclosure (500 ppm) prepared in the same manner as in test example 1 was sprayed on fresh healthy two weeks old cucumber plants.
  • the plants were air-dried and inoculated with freshly prepared spore suspension.
  • the inoculated plants were then placed in green house (25°C, a humidity of 60% and 16L8D) .
  • the percent disease control was assessed after 12 days from leaf disease area compared to control.
  • Compounds 1A-172 , 1A-181, 1A-254 , 1A-262, 1A-264, 1A-266, 1A-325, 1A-431, IB-33, IB-57, IB-60, IB-66 and lC-10 showed 80% or more control whereas the reference Compound A showed such a strong phytotoxicity on cucumber at 500 ppm that evaluation was impossible, and the reference Compound B and Flometoquin showed 100% and less than 70% control at 500 ppm, respectively.
  • the substituted pyrazole compounds or a salt thereof of the present disclosure shows an excellent controlling effect against a wide range of pests, such as aphids, spodoptera, mites, etc. and are useful as a pesticide agent for agricultural and horticultural use .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'objet de la présente invention est de fournir un nouveau composé de pyrazole substitué ou un sel de celui-ci tel que représenté par la formule (1) qui permet de lutter contre des organismes nuisibles : dans la formule Q représente un atome d'oxygène ou un atome de soufre, ou similaire ; R représente un aryle substitué ou non substitué, un alkyle en C1-C12, ou similaire ; représente l'hydrogène, alkylcarbonyle en C1- C12 substitué ou non substitué, alcoxycarbonyle en C1-C12 substitué ou non substitué ou similaire ; R2 et R3 représentent chacun indépendamment hydrogène, alkyle en C1-C12 substitué ou non substitué, ou similaire ; R4 et R5 représentent chacun indépendamment l'hydrogène, alkyle en C1- C12 substitué ou non substitué, ou similaire ; et X1, X2 et X3g représentent C-R8, C-Rg et C-R|0, respectivement, R8, R9 et Rjg représentant chacun indépendamment l'hydrogène, halogène, méthyle, éthyle ou similaire. Les composés de formule (1) sont utiles en tant qu'insecticides et fongicides.
PCT/IB2019/055483 2018-06-29 2019-06-28 Dérivés de pyrazole substitués à titre d'insecticides et de fongicides Ceased WO2020003219A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201811024217 2018-06-29
IN201811024217 2018-06-29

Publications (1)

Publication Number Publication Date
WO2020003219A1 true WO2020003219A1 (fr) 2020-01-02

Family

ID=67551583

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2019/055483 Ceased WO2020003219A1 (fr) 2018-06-29 2019-06-28 Dérivés de pyrazole substitués à titre d'insecticides et de fongicides

Country Status (2)

Country Link
TW (1) TW202012390A (fr)
WO (1) WO2020003219A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025238048A1 (fr) * 2024-05-15 2025-11-20 Syngenta Crop Protection Ag Compositions fongicides
US12503439B2 (en) 2022-04-22 2025-12-23 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168311A (en) 1973-12-10 1979-09-18 Hoechst Aktiengesellschaft Hydroxyquinoline carbamates and n-oxide hydroxyquinoline carbamates and their use as insecticides
JP2633377B2 (ja) 1989-07-07 1997-07-23 明治製菓株式会社 ４―アシルオキシキノリン誘導体及びこれを有効成分として含有する殺虫、殺ダニ剤
EP1382603A1 (fr) * 2001-04-26 2004-01-21 Eisai Co., Ltd. Compose azote a anneaux condenses possedant un groupe pyrazolyle et servant de substituant, et composition medicale le comprenant
WO2004026306A2 (fr) * 2002-09-18 2004-04-01 Pfizer Products Inc. Nouveaux composes de pyrazole utilises comme inhibiteurs du facteur de croissance transformant (tgf)
WO2006013896A1 (fr) 2004-08-04 2006-02-09 Meiji Seika Kaisha, Ltd. Dérivé de quinoline et insecticide contenant celui-ci comme constituant actif
WO2007088978A1 (fr) 2006-02-03 2007-08-09 Meiji Seika Kaisha, Ltd. Nouveau derive de quinoleine et pesticide destine a des applications agricoles et horticoles comprenant le derive en tant que principe actif
WO2008051272A2 (fr) * 2006-03-13 2008-05-02 Merck & Co., Inc. Agonistes de somatostatine
JP2008110953A (ja) 2006-10-31 2008-05-15 Meiji Seika Kaisha Ltd キノリン誘導体およびそれを含んでなる農園芸用殺虫剤
JP2009073776A (ja) * 2007-09-21 2009-04-09 Sumitomo Chemical Co Ltd 複素環化合物およびその有害節足動物防除剤
WO2015087231A1 (fr) * 2013-12-11 2015-06-18 Pfizer Limited Procédé de production de cellules d'épithélium pigmentaire de la rétine
WO2016092559A1 (fr) * 2014-12-12 2016-06-16 Oat & Iil India Laboratories Private Limited Dérivés de pyrazole substitués ayant une activité fongicide

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168311A (en) 1973-12-10 1979-09-18 Hoechst Aktiengesellschaft Hydroxyquinoline carbamates and n-oxide hydroxyquinoline carbamates and their use as insecticides
JP2633377B2 (ja) 1989-07-07 1997-07-23 明治製菓株式会社 ４―アシルオキシキノリン誘導体及びこれを有効成分として含有する殺虫、殺ダニ剤
EP1382603A1 (fr) * 2001-04-26 2004-01-21 Eisai Co., Ltd. Compose azote a anneaux condenses possedant un groupe pyrazolyle et servant de substituant, et composition medicale le comprenant
WO2004026306A2 (fr) * 2002-09-18 2004-04-01 Pfizer Products Inc. Nouveaux composes de pyrazole utilises comme inhibiteurs du facteur de croissance transformant (tgf)
WO2006013896A1 (fr) 2004-08-04 2006-02-09 Meiji Seika Kaisha, Ltd. Dérivé de quinoline et insecticide contenant celui-ci comme constituant actif
EP1780202A1 (fr) * 2004-08-04 2007-05-02 Meiji Seika Kaisha Ltd. Derive de quinoline et insecticide contenant cellui-ci comme constituant actif
WO2007088978A1 (fr) 2006-02-03 2007-08-09 Meiji Seika Kaisha, Ltd. Nouveau derive de quinoleine et pesticide destine a des applications agricoles et horticoles comprenant le derive en tant que principe actif
WO2008051272A2 (fr) * 2006-03-13 2008-05-02 Merck & Co., Inc. Agonistes de somatostatine
JP2008110953A (ja) 2006-10-31 2008-05-15 Meiji Seika Kaisha Ltd キノリン誘導体およびそれを含んでなる農園芸用殺虫剤
JP2009073776A (ja) * 2007-09-21 2009-04-09 Sumitomo Chemical Co Ltd 複素環化合物およびその有害節足動物防除剤
WO2015087231A1 (fr) * 2013-12-11 2015-06-18 Pfizer Limited Procédé de production de cellules d'épithélium pigmentaire de la rétine
WO2016092559A1 (fr) * 2014-12-12 2016-06-16 Oat & Iil India Laboratories Private Limited Dérivés de pyrazole substitués ayant une activité fongicide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHENG HUA JIN ET AL.: "Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-.beta. type 1 receptor kinase inhibitors", BIOORIGANIC & MEDICINAL CHEMISTRY, vol. 19, 2011, pages 2633 - 2640, XP002794438 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2009, TAKAOKA, DAISUKE: "Preparation of heterocyclic compounds as arthropod control agents", XP002794439, retrieved from STN Database accession no. 2009:422838 *
SCOTT E. WOLKENBERG ET AL: "Design, Synthesis, and Evaluation of Novel 3,6-Diaryl-4-aminoalkoxyquinolines as Selective Agonists of Somatostatin Receptor Subtype 2", JOURNAL OF MEDICINAL CHEMISTRY, vol. 54, no. 7, 14 April 2011 (2011-04-14), US, pages 2351 - 2358, XP055569581, ISSN: 0022-2623, DOI: 10.1021/jm101501b *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12503439B2 (en) 2022-04-22 2025-12-23 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
WO2025238048A1 (fr) * 2024-05-15 2025-11-20 Syngenta Crop Protection Ag Compositions fongicides

Also Published As

Publication number Publication date
TW202012390A (zh) 2020-04-01

Similar Documents

Publication Publication Date Title
CN113454079B (zh) 作为杀真菌化合物的杂环基哒嗪
KR100201426B1 (ko) 치환티오펜유도체 및 이것을 유효성분으로 하는 농원예용살균제
KR101397792B1 (ko) 테트라조일옥심 유도체 및 식물 병해 방제제
JPH0551582B2 (fr)
CN105636955A (zh) 四唑啉酮化合物及其用途
KR102348155B1 (ko) 신규한 벤질아미드 화합물, 이를 제조하는 방법, 및 살진드기제
TW201444801A (zh) 新穎之經鹵素取代的化合物
WO2018051252A2 (fr) Nouveau composé amide, son procédé de production et miticide
WO2020003219A1 (fr) Dérivés de pyrazole substitués à titre d'insecticides et de fongicides
JP2021502402A (ja) テトラゾリルプロピル誘導体および殺真菌剤としてのそれらの使用
JP2004346016A (ja) トリフルオロメチルキノキサリン化合物、その製造方法、及び有害生物防除剤
JP2005060255A (ja) カルボキサミド類及びこれを有効成分とする有害生物防除剤
CN105777640B (zh) 一种吡唑环己二醇醚类化合物及其应用
JP2002363164A (ja) ピラゾールカルボキサミド類、その中間体およびこれを有効成分とする有害生物防除剤
JP3966929B2 (ja) 置換ピラゾール誘導体、その製造方法およびそれを有効成分とする農園芸用殺菌剤
HK40006665A (en) Novel benzylamide compound, method for producing the same, and miticide
KR970002872B1 (ko) 사이클로헥산 유도체와 이의 염 및 이의 제조방법
JP2001151770A (ja) 置換チオフェン誘導体およびこれを有効成分とする農園芸用殺菌剤
WO2018015797A1 (fr) Nouveau composé de benzylamide, son procédé de production et miticide
WO2016063293A1 (fr) Nouveau composé imidazole 2-substitué et son utilisation
PH12015501304B1 (en) Pest control agent
HK40006665B (zh) 新颖的苯甲醯胺化合物、其制备方法及杀蟎剂
NZ267515A (en) 4-amino-2-quinolinone derivatives and biocidal compositions
JP2001172261A (ja) ピラゾールカルボン酸アミド類、およびこれを有効成分とする殺虫、殺ダニ剤
JP2001199984A (ja) ピラゾール−５−カルボン酸アミド類、およびこれを有効成分とする殺虫、殺ダニ剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19752259

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19752259

Country of ref document: EP

Kind code of ref document: A1